We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches (CRUZA)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2013 by Dana-Farber Cancer Institute.
Recruitment status was:  Enrolling by invitation
Sponsor:
ClinicalTrials.gov Identifier:
NCT01740219
First Posted: December 4, 2012
Last Update Posted: August 23, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
University of Massachusetts, Boston
Information provided by (Responsible Party):
Dana-Farber Cancer Institute
November 30, 2012
December 4, 2012
August 23, 2013
September 2011
September 2013   (Final data collection date for primary outcome measure)
Implementation [ Time Frame: 3-months ]
Number and types of interventions offered
Same as current
Complete list of historical versions of study NCT01740219 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches
Promoting the Utilization of Cancer Early Detection Methods Among Latinos in Church: a Faith-based Approach
This research study aims to develop an organizational-level intervention to enable communities to adopt, adapt, implement and sustain evidence-based interventions (EBIs) to address cancer disparities among Latinos. The investigators partner with faith-based organizations, since they play a highly prominent role in Latino community life. This three-phase study will: (1) improve understanding of the organizational infrastructure, skills and resources required by Latino churches to implement EBIs for cancer control, (2) develop a capacity-building intervention; and (3) test the intervention's effectiveness in a randomized trial.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Cancer
  • Behavioral: Capacity Enhancement
    Churches in the Capacity Enhancement intervention will be invited to work with CRUZA staff over the course of a three month intervention to implement health promotion activities in their church and participate in capacity-building educational workshops. Participants may also receive technical assistance from Health Educators in order to implement their cancer education activities.
  • Behavioral: Standard Dissemination
    Churches in the Standard Dissemination arm will receive program materials with information about cancer prevention/early detection and health resources.
  • Experimental: Capacity Enhancement
    Intervention: Behavioral: Capacity Enhancement
  • Experimental: Standard Dissemination
    Intervention: Behavioral: Standard Dissemination
Allen JD, Torres MI, Tom LS, Leyva B, Galeas AV, Ospino H. Dissemination of evidence-based cancer control interventions among Catholic faith-based organizations: results from the CRUZA randomized trial. Implement Sci. 2016 May 18;11(1):74. doi: 10.1186/s13012-016-0430-6.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
348
September 2013
September 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Parishes eligible for the Randomized trial are those that are: Roman Catholic, located in Massachusetts, offer religious services in Spanish, and have taken part in the organizational survey.

Exclusion Criteria:

  • Not Roman Catholic, not located in Massachusetts, don't offer religious services in Spanish, and have not participated in the organizational survey.
Sexes Eligible for Study: All
21 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01740219
19674
No
Not Provided
Not Provided
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Massachusetts, Boston
Principal Investigator: Jennifer D Allen, ScD Dana-Farber Cancer Institute
Principal Investigator: Maria Idali Torres, PhD University of Massachusetts, Boston
Dana-Farber Cancer Institute
August 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP